Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MAP kinase signalling pathways in cancer.

A S Dhillon1, S Hagan, O Rath

  • 1The Beatson Institute for Cancer Research, Bearsden, Glasgow, UK. a.dhillon@beatson.gla.ac.uk

Oncogene
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering the tumour immune microenvironment cell by cell.

Immuno-oncology technology·2023
Same author

Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte-Induced Lysis.

Scandinavian journal of immunology·2016
Same author

Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation.

Cell death and differentiation·2016
Same author

Differential expression of novel biomarkers (TLR-2, TLR-4, COX-2, and Nrf-2) of inflammation and oxidative stress in semen of leukocytospermia patients.

Andrology·2015
Same author

PR55α-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity.

Oncogene·2015
Same author

FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.

Oncogene·2014

Cancer involves cell communication errors, particularly in mitogen-activated protein kinase (MAPK) pathways. While Ras-Raf mutations drive cancer, stress-activated pathways may inhibit it, impacting treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cancer is fundamentally a disease of disrupted cellular communication.
  • Mitogen-activated protein kinase (MAPK) pathways are frequently implicated in cancer development.
  • Aberrations in these pathways are pleiotropic, affecting multiple cellular functions.

Purpose of the Study:

  • To review recent findings and hypotheses on the role of MAPK pathways in cancer.
  • To highlight specific MAPK pathway components frequently mutated in cancer.
  • To explore the contrasting roles of different MAPK pathways in tumorigenesis.

Main Methods:

  • Literature review of recent findings and hypotheses.
  • Discussion of genetic mutations in key MAPK pathway components.

Related Experiment Videos

  • Analysis of the functional roles of stress-activated versus growth-promoting MAPK pathways.

    • Main Results:

    • Mutations in Ras and B-Raf within the extracellular signal-regulated kinase (ERK) pathway are common in cancer.
    • Stress-activated pathways, including Jun N-terminal kinase (JNK) and p38, appear to counteract malignant transformation.
    • The interplay between different MAPK pathways varies across tumor types.

    Conclusions:

    • MAPK pathway signaling is critical in cancer biology.
    • Understanding the balance of MAPK pathway activity is crucial for predicting cancer outcomes.
    • Differential MAPK pathway activity influences sensitivity to cancer drug therapies.